More articles from 1-Minute Consult
- How do you effectively evaluate the elderly for alcohol use disorder?
A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.
- Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
Future need for permanent dialysis access is an important consideration.
What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?The risk of thrombosis should be balanced with the risk of bleeding.
- Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?
Yes. Corticosteroids are beneficial, and virtual visits are appropriate, especially in this pandemic.
- How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
Hemoglobin A1c is the standard but is not perfect. Alternatives are available.
- Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
The short answer is no—but it is not that simple.
- When is contrast needed for abdominal and pelvic CT?
The decision to use contrast depends on the diagnosis suspected.
- Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
Triple therapy is aggressive and carries high risks of bleeding and death.
- Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
Yes. Lacking guidelines, close surveillance is prudent.
- Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
No. Once troponin is over the 99th percentile, finding the peak value does not aid in diagnosis.
